Liu, X., Dai, Q., Ye, R., Zi, W., Liu, Y., Wang, H., Zhu, W., Ma, M., Yin, Q., Li, M., Fan, X., Sun, W., Han, Y., Lv, Q., Liu, R., Yang, D., Shi, Z., Zheng, D., Deng, X., Wan, Y., Wang, Z., Geng, Y., Chen, X., Zhou, Z., Liao, G., Jin, P., Liu, Y., Liu, X., Zhang, M., Zhou, F., Shi, H., Zhang, Y., Guo, F., Yin, C., Niu, G., Zhang, M., Cai, X., Zhu, Q., Chen, Z., Liang, Y., Li, B., Lin, M., Wang, W., Xu, H., Fu, X., Liu, W., Tian, X., Gong, Z., Shi, H., Wang, C., Lv, P., Tao, Z., Zhu, L., Yang, S., Hu, W., Jiang, P., Liebeskind, D. S., Pereira, V. M., Leung, T., Yan, B., Davis, S., Xu, G., Nogueira, R. G., & , (2020). endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet neurology, 19(2), 115–122. http://access.bl.uk/ark:/81055/vdc_100099353907.0x00000b